News
GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...
14hon MSN
Researchers at the National University of Singapore (NUS) have found new applications of magnetic field therapy with ...
15h
GlobalData on MSNApnimed sets sights on sleep apnoea pill approval following Phase III winPositive topline results of the LunAIRo trial put AD109 on track for approval as the first oral sleep apnoea medication.
The corner of 31st Avenue and 12th Street was the target location for the Gulfport branch of Mississippi Drug and Alcohol ...
ODMAP in Yakima County went live in March 2024, first with law enforcement agencies entering data through the Spillman record ...
In a complete response letter, the FDA indicates the drug trial is not an adequate, well-controlled clinical investigation, ...
23h
Vietnam Investment Review on MSNPharma sector faces up to AI hurdlesWhile AI and innovation are generating increasing spillover effects in the global pharmaceutical industry and improving ...
Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...
Everest Medicines (HKEX 1952.HK, 'Everest' or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...
London: GSK plc has announced the extension of the US Food and Drug Administration (FDA) review period for the Biologics ...
Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing ...
Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results